| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/11/2009 | CN100467045C Cancer treating medicine composition and its preparing method |
| 03/11/2009 | CN100467042C Indiscerptible and built in type Chinese traditional preparation for gynecopathy and its preparation process |
| 03/11/2009 | CN100467039C Application of a Chinese and western medicine combination for preventing and treating vision syndrome due to television and computer display screen light injury |
| 03/11/2009 | CN100467038C Biological and pharmacological effects and preparation process of liver protecting preparation containing vitamins |
| 03/11/2009 | CN100467036C Soft capsule of acetic acid of hawkthorn, and preparation method |
| 03/11/2009 | CN100467035C Medicine for treating frequent micturition and its preparaton method |
| 03/11/2009 | CN100467034C Cough stopping drip pills and its preparation process |
| 03/11/2009 | CN100467032C Medicinal bolus with functions of dilating vessels and removing blood stasis and its preparing process |
| 03/11/2009 | CN100467028C Compound nucleotide oral liquor for improving immunity and its preparing method |
| 03/11/2009 | CN100467024C Lornoxicam composition for injection and preparation process thereof |
| 03/11/2009 | CN100467020C Matrix type patch containing bronchodilators |
| 03/11/2009 | CN100467019C Anti-inflammatory cream and production thereof |
| 03/11/2009 | CN100467018C Jinlian heat-clearing capsule |
| 03/11/2009 | CN100467017C Effervescence tablet of Chinese magnoliavine fruit and its preparation process |
| 03/11/2009 | CN100467016C Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 03/11/2009 | CN100467015C A pharmaceutical composition for treating kidney-qi deficiency syndrome and preparation method thereof |
| 03/11/2009 | CN100467014C Method of preparing particles for agglomeration |
| 03/11/2009 | CN100467013C Coated magnolia fargesii volatile oil nano liposome nasal drops |
| 03/11/2009 | CN100467012C Separately packed structural fatty milk, aminoacid and glucose injection composition and the preparation process |
| 03/11/2009 | CN100467011C Temperature sensitive state-changing hydrogel composition and preparation method thereof |
| 03/10/2009 | US7501542 Highly-packed polycationic ammonium, sulfonium and phosphonium lipids |
| 03/10/2009 | US7501493 Dried blood factor composition comprising trehalose |
| 03/10/2009 | US7501485 Wound heraling agents; polypeptide |
| 03/10/2009 | US7501455 For parental injection of water insoluble drugs such as paclitaxel, propofol, amphotericin B, camptothecin, gemfibrozil and cyclosporin A; plasma protein such as serum albumin, an immunoglobulin, a glycoprotein, an interferon, or an interleukin, in controlled aggregation state |
| 03/10/2009 | US7501450 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 03/10/2009 | US7501409 A tablet has an acid, with reduced solubility in the neutral and alkaline regions, is used for treating sexual disorders erectile dysfunction |
| 03/10/2009 | US7501399 Immunoeffector compounds |
| 03/10/2009 | US7501134 Biodegradable, formed without the use of surfactant; diagnosis, therapy vaccines, and/or in raising immune response; poly(D,L-lactide-co-glycolide) and antigens such as HIV antigens, meningitis B antigens, streptococcus antigens, hepatitis B virus antigens, hepatitis C virus antigens, pertussis antigens |
| 03/10/2009 | US7501116 Placental alkaline phosphatase to control diabetes |
| 03/10/2009 | US7501113 Aerosol formulations and aerosol delivery of buprenorphine |
| 03/10/2009 | US7501061 Heating; using antiseptic membrane; high purity water for medical injections |
| 03/10/2009 | US7500444 Actuation indicator for a dispensing device |
| 03/10/2009 | CA2504489C Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| 03/10/2009 | CA2449856C Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
| 03/10/2009 | CA2430288C A composition improved in the solubility or oral absorbability |
| 03/10/2009 | CA2415068C Oral compositions comprising antimicrobial agents |
| 03/10/2009 | CA2392164C Implantable, refillable infusion device and septum replacement kit |
| 03/10/2009 | CA2363071C Injection molding process for neutral and acid-group containing (meth)acrylate copolymers |
| 03/10/2009 | CA2328998C Method of fabricating a banded prolonged release active agent dosage form |
| 03/10/2009 | CA2301057C A method of administering liposomal encapsulated taxane |
| 03/05/2009 | WO2009029958A2 Implantable delivery device |
| 03/05/2009 | WO2009029935A1 Drug delivery vehicle that mimics viral properties |
| 03/05/2009 | WO2009029899A1 Controlling body fluid condition using diuretics |
| 03/05/2009 | WO2009029888A2 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
| 03/05/2009 | WO2009029866A2 Minimizing trauma during and after insertion of a cochlear lead |
| 03/05/2009 | WO2009029795A1 Solid-state protein formulation |
| 03/05/2009 | WO2009029406A1 Delivery and controlled release of encapsulated lipophilic nutrients |
| 03/05/2009 | WO2009029046A1 Sugar-based surfactant microemulsions containing essential oils for cosmetic and pharmaceutical use |
| 03/05/2009 | WO2009028965A1 Surgical hydrogel |
| 03/05/2009 | WO2009028900A2 Oral administration drug comprising clopidogrel besylate |
| 03/05/2009 | WO2009028764A1 Thermo-reversible coacervate combination gels for protein delivery |
| 03/05/2009 | WO2009028674A1 Latanoprost-containing aqueous pharmaceutical composition |
| 03/05/2009 | WO2009028650A1 Emulsion-type external preparation, and method for production thereof |
| 03/05/2009 | WO2009028649A1 Method for reduction in volume of solid preparation having high amino acid content |
| 03/05/2009 | WO2009028598A1 Sustained release preparation and process for production thereof |
| 03/05/2009 | WO2009028583A1 Process for producing coated preparation |
| 03/05/2009 | WO2009028487A1 Process for production of tablets containing both crystalline cellulose and granules |
| 03/05/2009 | WO2009027877A1 Stabilized decolorizing composition |
| 03/05/2009 | WO2009027866A2 Anti-microbial substrates with peroxide treatment |
| 03/05/2009 | WO2009027786A2 Matrix dosage forms of varenicline |
| 03/05/2009 | WO2009027745A1 Pharmaceutical formulation for extended release |
| 03/05/2009 | WO2009027705A1 Pharmaceutical powder compositions comprising a benzodiazepine drug and chitosan |
| 03/05/2009 | WO2009027697A2 Non-aqueous pharmaceutical compositions |
| 03/05/2009 | WO2009027644A2 Compositions for the treatment of neoplastic diseases |
| 03/05/2009 | WO2009027561A2 Oral pharmaceutical desmopressin composition |
| 03/05/2009 | WO2009027521A1 Carrier-free orodispersible and/or dispersible solid composition with noticeable effect and method for preparing same |
| 03/05/2009 | WO2009027506A2 Local topical administration formulations containing fipronil |
| 03/05/2009 | WO2009027478A2 A method of removing preservatives from a liquid pharmaceutical preparation |
| 03/05/2009 | WO2009027337A1 Liposomal dispersion and dry powder formulations comprising oligonucleotides having improved downstream prossessing properties |
| 03/05/2009 | WO2009027324A1 Method for the dispersion of ionic nanoparticles |
| 03/05/2009 | WO2009027095A1 Aerosols for sinunasal drug delivery |
| 03/05/2009 | WO2009027076A1 Liquid formulation of g-csf |
| 03/05/2009 | WO2009026816A1 The application of 1-aryl-2(1h)-pyridone compounds in preparation of medincines for treating itching of the skin |
| 03/05/2009 | WO2009026790A1 Crystal entecavir fomulation and the preparation method thereof |
| 03/05/2009 | WO2009026680A1 Supramacrqmolecular polymer complexes providing controlled nitric oxide release for healing wounds |
| 03/05/2009 | WO2009026621A1 Pharmaceutical compound & composition |
| 03/05/2009 | WO2009012303A9 Therapeutic stable nanoparticles |
| 03/05/2009 | WO2009010305A3 Tablettable formulations of lipophilic health ingredients |
| 03/05/2009 | WO2009008004A3 Sustained release formulations of divalproex sodium |
| 03/05/2009 | WO2009007808A4 Combined pharmaceutical composition |
| 03/05/2009 | WO2009005814A3 Drug-delivery patch comprising a dissolvable layer and uses thereof |
| 03/05/2009 | WO2009002867A3 Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| 03/05/2009 | WO2009002386A3 Size-dependent biological effect of nanoparticles |
| 03/05/2009 | WO2008151775A3 Hyperbranched polymers based on cyclodextrins and poly(amidoamines) for the controlled release of insoluble drugs |
| 03/05/2009 | WO2008150995A3 Transdermal drug delivery systems for delivering anti-inflammatory drugs |
| 03/05/2009 | WO2008143812A3 Biologic devices for hemostasis |
| 03/05/2009 | WO2008139263A3 Methods for slowing the progression of multiple sclerosis |
| 03/05/2009 | WO2008135090A8 Solid dosage forms comprising an enteric coating with accelerated drug release |
| 03/05/2009 | WO2008129106A3 Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof |
| 03/05/2009 | WO2008128115A3 Low-dose doxepin formulations |
| 03/05/2009 | WO2008119659A3 Pharmaceutical composition and process |
| 03/05/2009 | WO2008105791A3 Collagen scaffolds, medical implants with same and methods of use |
| 03/05/2009 | WO2008092826A3 Cistus extracts |
| 03/05/2009 | WO2008080092A8 Compositions comprising bile acid sequestrants for treating esophageal disorders |
| 03/05/2009 | WO2008078189A3 Factor vii and viia compositions |
| 03/05/2009 | WO2008055620A3 Method for the production of an agent against an infectious disease |
| 03/05/2009 | WO2008051617A3 Dry granulated pharmaceutical compositions and methods for producing same |
| 03/05/2009 | WO2007132205A3 Nanoparticle pharmaceutical carrier |
| 03/05/2009 | US20090062904 Stent coating |
| 03/05/2009 | US20090062778 Medical System Comprising Dual-Purpose Communication Means |